Yunkang Group (HKSE:02325) Equity-to-Asset : 0.47 (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Yunkang Group Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Yunkang Group's Total Stockholders Equity for the quarter that ended in Dec. 2023 was HK$2,310.2 Mil. Yunkang Group's Total Assets for the quarter that ended in Dec. 2023 was HK$4,957.1 Mil. Therefore, Yunkang Group's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.47.

The historical rank and industry rank for Yunkang Group's Equity-to-Asset or its related term are showing as below:

HKSE:02325' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.47 Med: 0.56 Max: 0.63
Current: 0.47

During the past 6 years, the highest Equity to Asset Ratio of Yunkang Group was 0.63. The lowest was 0.47. And the median was 0.56.

HKSE:02325's Equity-to-Asset is ranked worse than
64.38% of 233 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.58 vs HKSE:02325: 0.47

Yunkang Group Equity-to-Asset Historical Data

The historical data trend for Yunkang Group's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yunkang Group Equity-to-Asset Chart

Yunkang Group Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Equity-to-Asset

Get a 7-Day Free Trial

0.61

0.54

0.59

0.52

0.47

Yunkang Group Semi-Annual Data
	Dec18	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Equity-to-Asset	Get a 7-Day Free Trial				0.59	0.63	0.52	0.50	0.47

Competitive Comparison of Yunkang Group's Equity-to-Asset

For the Diagnostics & Research subindustry, Yunkang Group's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Yunkang Group's Equity-to-Asset Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Yunkang Group's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Yunkang Group's Equity-to-Asset falls into.

Yunkang Group Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Yunkang Group's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	2310.227	/	4957.063
	=	0.47

Yunkang Group's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	2310.227	/	4957.063
	=	0.47

Yunkang Group (HKSE:02325) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Yunkang Group Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Yunkang Group's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Yunkang Group (HKSE:02325) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Yunkang Group Ltd (HKSE:02325) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 6 Lizhishan Road, Science City, Huangpu District, Guangzhou, CHN

Website

http://www.yunkanghealth.com

Yunkang Group Ltd is a medical operation service provider in China. The company has three major business lines namely covering diagnostic testing services for medical consortia, diagnostic outsourcing services, and non-medical institutions.

Executives

Huizekx Limited	2201 Interest of corporation controlled by you
Yk Development Limited	2101 Beneficial owner
Zhang Yong	2201 Interest of corporation controlled by you
Shanghai Pudong Development Bank Co., Ltd	2201 Interest of corporation controlled by you
Zhou Xinyu
Guang Zhou Da An Ji Yin Gu Fen You Xian Gong Si	2201 Interest of corporation controlled by you
Da An Guo Ji Ji Tuan You Xian Gong Si	2101 Beneficial owner
Guang Zhou Shi Da An Ji Yin Ke Ji You Xian Gong Si	2201 Interest of corporation controlled by you
Jin Jun Ying Limited	2201 Interest of corporation controlled by you
Mouduans Limited	2201 Interest of corporation controlled by you
Source Capital Rw Limited	2201 Interest of corporation controlled by you
Tongfuzc Limited	2201 Interest of corporation controlled by you
Wjjr Investment Limited	2201 Interest of corporation controlled by you

Yunkang Group (HKSE:02325) Headlines

No Headlines